In vivo antibacterial effects of tretinoin-clindamycin and clindamycin alone on Propionibacterium acnes with varying clindamycin minimum inhibitory concentration levels

Journal of Drugs in Dermatology

Volumn 11, Issue 12, 2012, Pages 1434-1438

  Leyden, James J ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLINDAMYCIN PHOSPHATE; CLINDAMYCIN PHOSPHATE PLUS RETINOIC ACID;

ADULT; ANTIBACTERIAL ACTIVITY; ANTIBIOTIC SENSITIVITY; ARTICLE; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; IN VIVO STUDY; MALE; MINIMUM INHIBITORY CONCENTRATION; MONOTHERAPY; OPEN STUDY; PROPIONIBACTERIUM ACNES; RANDOMIZED CONTROLLED TRIAL;

ADULT; AGED; ANTI-BACTERIAL AGENTS; BACTERIAL LOAD; CLINDAMYCIN; DRUG COMBINATIONS; DRUG RESISTANCE, MICROBIAL; ERYTHROMYCIN; FEMALE; HUMANS; KERATOLYTIC AGENTS; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; PROPIONIBACTERIUM ACNES; SKIN; TRETINOIN; YOUNG ADULT;

EID: 84871039412     PISSN: 15459616     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. McGinley KJ, Webster GF, Leyden JJ. Regional variations of cutaneous propionibacteria. Appl Environ Microbiol. 1978;35(1):62-66. (Pubitemid 8275052)
2. Bojar RA, Holland KT. Acne and Propionibacterium acnes. Clin Dermatol. 2004;22(5):375-379. (Pubitemid 39535278)
3. Bhambri S, Del Rosso JQ, Bhambri A. Pathogenesis of acne vulgaris: recent advances. J Drugs Dermatol. 2009;8(7):615-618.
4. Jappe U. Pathological mechanisms of acne with special emphasis on Propionibacterium acnes and related therapy. Acta Derm Venereol. 2003;83(4):241-248. (Pubitemid 36920596)
5. Webster GF. Acne vulgaris. BMJ. 2002;325(7362):475-479.
6. Toyoda M, Morohashi M. Pathogenesis of acne. Med Electron Microsc. 2001;34(1):29-40.
7. Ross JI, Snelling AM, Eady EA, et al. Phenotypic and genotypic characterization of antibiotic-resistant Propionibacterium acnes isolated from acne patients attending dermatology clinics in Europe, the U.S.A., Japan and Australia. Br J Dermatol. 2001;144(2):339-346. (Pubitemid 32178816)
8. Cooper AJ. Systematic review of Propionibacterium acnes resistance to systemic antibiotics. Med J Aust. 1998;169(5):259-261. (Pubitemid 28432848)
9. Leyden JJ, Del Rosso JQ, Webster GF. Clinical considerations in the treatment of acne vulgaris and other inflammatory skin disorders: a status report. Dermatol Clin. 2009;27(1):1-15.
10. Williamson P, Kligman AM. A new method for the quantitative investigation of cutaneous bacteria. J Invest Dermatol. 1965;45(6):498-503.
11. Keyworth N, Millar MR, Holland KT. Swab-wash method for quantitation of cutaneous microflora. J Clin Microbiol. 1990;28(5):941-943. (Pubitemid 20141204)
12. Dumont-Wallon G, Moyse D, Blouin E, Dréno B. Bacterial resistance in French acne patients. Int J Dermatol. 2010;49(3):283-288.
13. Ishida N, Nakaminami H, Noguchi N, Kurokawa I, Nishijima S, Sasatsu M. Antimicrobial susceptibilities of Propionibacterium acnes isolated from patients with acne vulgaris. Microbiol Immunol. 2008;52(12):621-624.
14. Oprica C, Löfmark S, Lund B, Edlund C, Emtestam L, Nord CE. Genetic basis of resistance in Propionibacterium acnes strains isolated from diverse types of infection in different European countries. Anaerobe. 2005;11(3):137-143. (Pubitemid 40410637)
15. Eady EA, Gloor M, Leyden JJ. Propionibacterium acnes resistance: a worldwide problem. Dermatology. 2003;206(1):54-56. (Pubitemid 36164666)
16. Coates P, Vyakrnam S, Eady EA, Jones CE, Cove JH, Cunliffe WJ. Prevalence of antibiotic-resistant propionibacteria on the skin of acne patients: 10-year surveillance data and snapshot distribution study. Br J Dermatol. 2002;146(5):840-848. (Pubitemid 34539195)
17. Ross JI, Snelling AM, Carnegie E, et al. Antibiotic-resistant acne: lessons from Europe. Br J Dermatol. 2003;148(3):467-478. (Pubitemid 36461325)
18. Eady EA, Jones CE, Tipper JL, Cove JH, Cunliffe WJ, Layton AM. Antibiotic resistant propionibacteria in acne: need for policies to modify antibiotic usage. Br Med J. 1993;306(6877):555-556. (Pubitemid 23056875)
19. Leyden J. Topical antimicrobial agents and acne therapy. Dermatol Ther. 1998;6:35-38. (Pubitemid 28505509)
20. Pechère M, Germanier L, Siegenthaler G, Pechère JC, Saurat JH. The antibacterial activity of topical retinoids: the case of retinaldehyde. Dermatology. 2002;205(2):153-158.
21. Del Rosso J, Schmidt NF. A review of the anti-inflammatory properties of clindamycin in the treatment of acne vulgaris. Cutis. 2010;85(1):15-24.